Jinsun Park

Jinsun Park

Auto-generated profile, based on publicly available information

Jinsun Park

Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2021 in Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
JPJin Sun Park
Jin Sun Park
SYSoo Jin Yun
Soo Jin Yun
JLJung Kuk Lee
Jung Kuk Lee
SPSo Young Park
So Young Park
SCSang Ouk chin
Sang Ouk chin
Only a few studies have established the epidemiology of prolactinoma and Cushing's disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing's disease and their survival analysis according to treatment. The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing's disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used. The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing's disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing's disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing's disease ameliorated the survival rate significantly. Overall, the incidence of prolactinoma and Cushing's disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing's disease for improving the survival rate.

27 March 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
KLKyung‐Yeon Lee
Kyung‐Yeon Lee
JPJinsun Park
Jinsun Park
JCJungMin Choi
JungMin Choi
HAHyo‐Jeong Ahn
Hyo‐Jeong Ahn
SKSoonil Kwon
Soonil Kwon
SLSo‑Ryoung Lee
So‑Ryoung Lee
Backgrounds and Aims: Left bundle branch area pacing (LBBAP) has been shown to reduce the risk of pacing‐facilitated heart failure (HF) compared to right ventricular pacing (RVP), but limited data exists comparing LBBAP with stylet‐driven leads (SDL) and conventional RVP. The study aims to compare clinical outcomes between LBBAP using SDL and conventional RVP.Methods: From December 2018 to December 2023, patients who underwent pacemaker implantation at two tertiary hospitals were enrolled. Exclusions included those requiring cardiac resynchronization therapy and patients with ventricular pacing burden ≤ 10%. LBBAP was performed using SDL (Solia S60, Biotronik) with a fixed curve delivery sheath. Composite outcome I consisted of HF admission, pacing‐induced cardiomyopathy (defined as an LVEF decline of ≥ 10% or below 50%), and upgrade to biventricular pacing. Composite outcome II included all‐cause death in addition to the components of composite outcome I.Results: A total of 738 patients (mean age 72.1 years; 52% of men; 243 LBBAP vs. 495 RVP) were included. Atrioventricular block was more common pacing indication in LBBAP group than RVP group (88.1% vs. 69.3%, p < 0.001). Compared to RVP group, ventricular pacing burden was higher in the LBBAP group (96% vs. 86%, p < 0.001). LBBAP was associated with a lower risk of composite outcome I and II compared to RVP (adjusted HR 0.27 [95% confidence interval 0.11–0.68], p = 0.006 for composite outcome I, aHR 0.41 [0.20–0.84], p = 0.015 for composite outcome II), mainly driven by a lower risk of pacing‐induced cardiomyopathy by 70%. There were no significant differences in procedure‐related complications.Conclusion: LBBAP with SDL was associated with a lower risk of adverse clinical outcomes compared to conventional RVP in patients requiring substantial ventricular pacing.

18 June 2024 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
JPJinsun Park
Jinsun Park
MCMyung-Jin Cha
Myung-Jin Cha
CKChang Hee Kwon
Chang Hee Kwon
MCMin Soo Cho
Min Soo Cho
GNGi-Byoung Nam
Gi-Byoung Nam
HLHong Euy Lim
Hong Euy Lim
Introduction: The impact of early recurrence of atrial tachyarrhythmia (ERAT) within the 90‐day blanking period on long‐term outcomes in atrial fibrillation (AF) patients undergoing cryoballoon ablation (CBA) is controversial. This study aimed to assess the relationship between ERAT and late recurrence of atrial tachyarrhythmia (LRAT) post‐CBA.Methods: Utilizing data from a multicenter registry in Korea (May 2018 to June 2022), we analyzed the presence and timing of ERAT (<30, 30–60, and 60–90 days) and its association with LRAT risk after CBA. LRAT was defined as any recurrence of AF, atrial flutter, or atrial tachycardia lasting more than 30 s beyond the 90 days.Results: Out of 2636 patients, 745 (28.2%) experienced ERAT post‐CBA. Over an average follow‐up period of 21.2 ± 10.3 months, LRAT was observed in 874 (33.1%) patients. Patients with ERAT had significantly lower 1‐year LRAT freedom compared to those without ERAT (42.6% vs. 85.5%, p < .001). Multivariate analysis identified ERAT as a potential predictor of LRAT, with a hazard ratio (HR) of 3.98 (95% confidence interval [CI], 3.47–4.57). Significant associations were noted across all examined time frames (HR, 3.84; 95% CI, 3.32–4.45 in <30 days, HR, 5.53; 95% CI, 4.13–7.42 in 30–60 days, and HR, 4.29; 95% CI, 3.12–5.89 in 60–90 days). This finding was consistently observed across all types of AF.Conclusion: ERAT during the 90‐day blanking period strongly predicts LRAT in AF patients undergoing CBA, indicating a need to reconsider the clinical significance of this period.

1 February 2026 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
JPJinsun Park
Jinsun Park
MCMyung-Jin Cha
Myung-Jin Cha
MCMin Soo Cho
Min Soo Cho
GNGi-Byoung Nam
Gi-Byoung Nam
KCKee-Joon Choi
Kee-Joon Choi
JKJune-Hong Kim
June-Hong Kim
Aims: Adequate sedation and analgesia are essential for catheter ablation of atrial fibrillation (AF) to ensure patient comfort and procedural safety. However, the availability of cardiac anaesthesiology is limited. This study evaluated the efficacy and safety of an operator-directed, nurse-administered (ODNA) sedation protocol using propofol and remifentanil during AF ablation. Methods and results: In this prospective, single-centre observational cohort study, consecutive patients undergoing catheter ablation for AF from August 2023 to March 2024 were enrolled. Sedation-related adverse events and intra-procedural vital signs were recorded. Sedation depth was assessed using the Modified Observer’s Alertness/Sedation (MOAA/S) scale, and patient satisfaction was evaluated using the Visual Analogue Scale (VAS). A total of 230 patients were included (mean age 61.9 years; 76.1% male). Of these, 7.4% had a body mass index of ≥30 kg/m2, and 4.3% had obstructive sleep apnoea. Paroxysmal AF accounted for 30.9%, and the mean procedure time was 174 min. The primary outcome—defined as unplanned sedation interruption, intubation, or continuous vasopressor requirement—occurred in 2.2% of patients. Intermittent hypotension (mean arterial pressure: <60 mmHg) occurred in 36.1% of patients, but no patient required continuous vasopressors. The mean MOAA/S score was 0.4 ± 0.4. Post-procedural surveys showed high satisfaction (mean VAS: 8.8) and low maximal pain (VAS: 0.9). Conclusion: An ODNA protocol using propofol and remifentanil provides effective and safe sedation for AF ablation, with high patient satisfaction and minimal serious adverse events.

6 September 2026 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
JPJinsun Park
Jinsun Park
MCMyung-Jin Cha
Myung-Jin Cha
CKChang Hee Kwon
Chang Hee Kwon
MCMin Soo Cho
Min Soo Cho
GNGi-Byoung Nam
Gi-Byoung Nam
HLHong Euy Lim
Hong Euy Lim